Release date: February 2017
Valid through: February 2020
This activity is intended for the obstetrician and gynecologist and nurses in OB/GYN practices.
- Did You Remember to Take Your Hormone Replacement? The Treatment May Not Help
- Who Needs an Endometrial Biopsy?
- Laborists: How Will It Affect Care?
- Marijuana Use and Pregnancy
- Physical Activity, Exercise, Strength, Aging, and the Pelvic Floor
- Explain the latest data regarding diagnosis and treatment of various diseases affecting women
- Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
- Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women
- Maximum of 2.25 AMA PRA Category 1 Credits™
This activity is sponsored by AHC Media.
AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Jeffrey T. Jensen, MD, MPH, Leon Speroff Professor and Vice Chair for Research, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland
Rebecca H. Allen, MD, Associate Professor, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, RI
John C. Hobbins, MD, Professor, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora
Chiara Ghetti, MD, Associate Professor, Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Washington University School of Medicine, St. Louis
Medical Editor: Jeffrey T. Jensen, MD, MPH
Peer Reviewer: Catherine Leclair, MD
Nurse Planner: Marci Messerle Forbes, RN, FNP
Nurse Planner: Andrea O’Donnell, RN, FNP
AHC Media Executive Editor: Leslie G. Coplin
Assistant Editor: Jonathan Springston
Jeffrey T. Jensen, MD, MPH reports he is a consultant for and receives grant/research support from Bayer, Abbvie, ContraMed, and Merck he receives grant research support from Medicines360, Agile and Teva, and is a consultant for MicroChips and Evofem. Rebecca H. Allen reports she is a Nexplanon trainer for Merck, and she has served on advisory boards for Bayer and Pharmanest. John C. Hobbins, MD and Chiara Ghetti, MD report no financial relationships relevant to this field of study.
OB/GYN Clinical Alert's Editor, Jeffrey T. Jensen, MD, MPH, reports he is a consultant for and receives grant/research support from Bayer, Abbvie, ContraMed, and Merck he receives grant research support from Medicines360, Agile and Teva, and is a consultant for MicroChips and Evofem.
Peer Reviewer Catherine Leclair, MD, Nurse Planners Marci Messerle Forbes, RN, FNP, and Andrea O’Donnell, RN, FNP, Executive Editor Leslie G. Coplin, and Assistant Editor Jonathan Springston report no financial relationships relevant to this field of study.
Copyright 2017, AHC Media. All rights reserved.
This course is no longer available to take.